Linkage and association of DRD2 gene TagI polymorphism with schizophrenia in an Iranian population

Archives of Iranian Medicine

Volumn 11, Issue 3, 2008, Pages 252-256

  Behravan, Javad ^a   Hemayatkar, Mehdi ^a   Toufani, Hamid ^a   Abdollahian, Ebrahim ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DRD2 gene; Polymorphism; Schizophrenia; Taql

Indexed keywords

DNA FRAGMENT; DOPAMINE 2 RECEPTOR; NUCLEOTIDYLTRANSFERASE; TAQ POLYMERASE; TAQ1A POLYMERASE; TAQ1B POLYMERASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRAN; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE;

ARABS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IRAN; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; SEX FACTORS; TAQ POLYMERASE;

EID: 44849138719     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hanson DR, Gottesman I. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Gen. 2005; 6:1-17.
2. McGuffin P, Owen MJ, Farmer AE. The genetic basis of schizophrenia. Lancet. 1995; 346: 678-682.
3. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991; 148: 1474-1486.
4. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1987; 1: 133-152.
5. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998; 78: 189-225.
6. Ambrosio AM, Kennedy JL, Macciardi F, Macedo A, Valente J, Dourado A, et al. Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population. Psychiatry Res. 2004; 125:185-191.
7. Asherson P, Williams N, Roberts E, McGuffin M, Owen M. DRD2 Ser311/ Cys311 polymorphism in schizophrenia. Lancet. 1994; 343: 1045.
8. Blum K, Braverman ER, Wu S, Cull JG, Chen TJ, Gill J, et al. Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry. 1997; 2: 239-246.
9. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr Res. 2001; 49: 203-212.
10. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H. The human dopamine D2 receptor gene is located on chromosome 11 a q22-q23 and identifies a TaqI RFLP. Am J Hum Genet. 1989; 45: 778-785.
11. Hauge XY, Grandy DK, Eubanks JH, Evans GA, Civelli O, Litt M. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics. 1991; 10: 527-530.
12. Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, et al. The 3' region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res. 2004; 67: 75-85.
13. Wu S, Xing Q, Gao R, Li X, Gu N, Feng G, et al. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients. Neurosci Lett. 2005; 376: 1-4.
14. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK, et al. The A1 allele of human D2 dopamine receptor availability in healthy volunteers. Mol Psychiatry. 1998; 3: 256-260.
15. Dollfus S, Campion D, Vasse T, Preterre P, Laurent C, d' Amato T, et al. Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems. Biol Psychiatry. 1996; 40: 419-421.
16. Jonsson E, Brene S, Geiger T, Terenius L, Tylec A, Persson ML, et al. A search for association between dopamine-related alleles. Eur Arch Psychiatry Clin Neurosci. 1996; 246: 297-304.
17. Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141CIns/Del polymorphism. Psychiatr Clin Neurosci. 2002; 56: 97-102.
18. Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J. Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia. Am J Med Genet. 2001; 105: 176-178.
19. Lahirini DK, Narnberger JI. A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991; 19: 5444.
20. Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Champberlain RM, et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Canc Inst. 1998; 90: 358-363.
21. Suzuki A, Kondo T, Mihara K, Furukori H, Nagashima U, Ono S, et al. Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients. Prog Neuropsychopharmacol Biol Psychiatry. 2000; 24: 1105-1113.
22. Suzuki A, Mihara K, Kondo T, Tanaka O, Nagashima U, Otani K, et al. The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients. Pharmacogenetics. 2000; 10: 335-341.
23. Breen G, Brown J, Maude S, Fox H, Collier D, Li T, et al. -141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. Am J Med Genet. 1999; 88: 407-410.
24. Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet. 1998; 81: 24-28.
25. Mihara K, Suzuki A, Kondo T, Nagashima U, Ono S, Otani K, et al. No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study. Am J Med Genet. 2000; 96(3): 422-424.
26. Amadeo S, Abbar M, Fourcade ML, Waksman G, Leroux MG, Madec A, et al. D2 dopamine receptor gene and alcoholism. J Psychiatr Res. 1993; 27: 173-179.
27. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend. 1994; 34:175-180.
28. Blum K, Braverman ER, Wood RC, Gill J, Li C, Chen TJ, et al. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics. 1996; 6: 297-305.
29. Lee MS, Lee HJ, Kwang-Yoon S. Distribution of the TaqI polymorphism of the dopamine D2 receptor in a Korean schizophrenic population. Psychiatr Genet. 1995; 5: S59.
30. Comings D, Comings BG, Muhleman D, Shahbahrami B, Tast D, Knell E, et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J Am Med Assoc. 1991; 266: 1793-1800.
31. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Ozkaragoz T, et al. Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics. Alcohol. 1993; 10: 59-67.
32. Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2000; 9: 1021-1026.